<html><head><title>2024-03-01</title><link rel="stylesheet" type="text/css" href="static/table.css"/></head><body><table id="container">
  <thead>
    <tr style="text-align: right;">
      <th role="columnheader">No.</th>
      <th role="columnheader">capSize</th>
      <th role="columnheader">stock</th>
      <th role="columnheader">chance</th>
      <th role="columnheader">risk</th>
      <th role="columnheader">tags</th>
      <th role="columnheader">Volatility</th>
      <th role="columnheader">YTD%</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>1</td>
      <td>Middle</td>
      <td><a href="https://xueqiu.com/S/GEHC">GEHC<br>GE HealthCare</a></td>
      <td>1. GE HealthCare is making significant advancements in ultrasound technology with the launch of its new LOGIQ portfolio, showcasing the company’s commitment to advancing precision care.<br>2. Strategic collaboration with Biofourmis demonstrates GE HealthCare’s focus on enhancing continuity of care by providing innovative home care solutions.<br>3. Collaboration with OSF HealthCare and Pointcore, Inc. aims to improve clinical and operational efficiencies, standardize care delivery models, and enhance patient outcomes.<br>4. The successful pricing and launch of a secondary underwritten public offering indicates investor confidence in GE HealthCare Technologies.<br>5. Upcoming presentation at investor conferences presents an opportunity for potential investors to gain insights into GE HealthCare’s financial performance and future prospects.</td>
      <td>1. Competition in the medical technology and pharmaceutical diagnostics industry may pose challenges for GE HealthCare in maintaining market share and profit margins.<br>2. Regulatory changes and healthcare policy reforms could impact the demand for GE HealthCare’s products and services.<br>3. Fluctuations in global economic conditions and healthcare spending may affect the company’s revenue and financial performance.</td>
      <td>Medical Technology<br>Ultrasound<br>Home Care Solutions<br>Collaborations<br>Investor Conferences</td>
      <td>282.66</td>
      <td>21.66</td>
    </tr>
    <tr>
      <td>2</td>
      <td>Large</td>
      <td><a href="https://xueqiu.com/S/IBM">IBM<br>IBM</a></td>
      <td>1. IBM closed at $185.03 in the latest trading session, marking a -0.15% move from the prior day.<br>2. IBM announced the availability of the popular open-source Mixtral-8x7B large language model (LLM) on its watsonx AI and data platform, as it continues to expand capabilities to help clients innovate.<br>3. A new global study by the IBM Institute for Business Value found that while a majority of organizations recognize sustainability as important to their business strategy, many C-suite leaders are struggling to fund their sustainability investments.</td>
      <td>1. Ned Davis Research strategist mentioned that the S&P 500's current bull run is short of historical averages, which could indicate a potential downturn in the market.<br>2. Deepfakes are one of the most pressing challenges posed by generative AI, which could potentially impact IBM's AI and data business.</td>
      <td>AI and data platform<br>Sustainability investments<br>Market trends<br>Financial outcomes<br>Generative AI</td>
      <td>501.77</td>
      <td>14.87</td>
    </tr>
    <tr>
      <td>3</td>
      <td>Small</td>
      <td><a href="https://xueqiu.com/S/SWN">SWN<br>nan</a></td>
      <td>1. Higher oil production and reduction in marketing purchases have aided Southwestern's Q4 earnings.<br>2. The longer-term bull case for natural gas rests on expanding U.S. exports, benefiting companies like Chesapeake Energy and Cheniere Energy.<br>3. Southwestern Energy delivered earnings and revenue surprises for the quarter ended December 2023, indicating strong performance compared to estimates and year-ago values.<br>4. Despite lower commodity prices, SWN announced strong cash flow in its 2023 earnings.<br>5. Southwestern Energy has an impressive earnings surprise history and currently possesses the right combination of key ingredients for a likely beat in its next quarterly report.</td>
      <td>1. Front-month gas futures for March delivery rose, but financial company LSEG reported rising gas output in the U.S. Lower 48 states, potentially impacting market dynamics.<br>2. Devon Energy doesn't possess the right combination of key ingredients for a likely earnings beat in its upcoming report.<br>3. Investors should carefully consider the impact of lower commodity prices on Southwestern Energy's future earnings and revenue.<br>4. CNX Resources Corporation delivered strong earnings and revenue surprises, indicating potential competition for Southwestern Energy in the natural gas sector.</td>
      <td>Natural Gas<br>Earnings<br>Commodity Prices<br>Market Dynamics<br>Investment Potential</td>
      <td>349.25</td>
      <td>8.57</td>
    </tr>
    <tr>
      <td>4</td>
      <td>Middle</td>
      <td><a href="https://xueqiu.com/S/DAL">DAL<br>Delta Air Lines</a></td>
      <td>1. Delta Air Lines (DAL) has seen year-to-date gains and is expected to benefit from the resilience of the consumer in the travel industry.<br>2. The strength of airline operators is being supported by customer loyalty programs and stability in fares, potentially leading to upside in revenues.</td>
      <td>1. Moderation in airline stock prices could occur, particularly due to fluctuations in oil prices.<br>2. Oversight concerns tied to the airline industry, especially with the FAA reauthorization expiring on March 8, could impact the industry.</td>
      <td>Airline Industry<br>Travel Sector<br>Fuel Prices<br>Consumer Resilience<br>Revenue Upside</td>
      <td>314.05</td>
      <td>2.90</td>
    </tr>
    <tr>
      <td>5</td>
      <td>Small</td>
      <td><a href="https://xueqiu.com/S/GDRX">GDRX<br>GoodRx</a></td>
      <td>1. GoodRx beat Q4 estimates and issued strong guidance for 2024, indicating positive growth potential<br>2. The company's new stock buyback program valued at $450 million demonstrates confidence in its future performance<br>3. GoodRx CEO Scott Wagner's emphasis on industry innovation and the company's leadership in AI technology bode well for future success</td>
      <td>1. Although revenue increased by 7%, the company encountered a net loss, indicating potential financial challenges<br>2. The healthcare industry is subject to regulatory and market volatility, which may impact GoodRx's performance<br>3. Competition in the digital health sector poses a risk to GoodRx's market position and profitability</td>
      <td>Healthcare<br>Digital Health<br>Earnings<br>Stock Buyback<br>AI Technology</td>
      <td>363.01</td>
      <td>23.65</td>
    </tr>
    <tr>
      <td>6</td>
      <td>Small</td>
      <td><a href="https://xueqiu.com/S/NYCB">NYCB<br>New York Community Bancorp</a></td>
      <td>1. NYCB is facing turmoil after discovering material weaknesses in tracking loan risks and reporting a tenfold increase in fourth-quarter loss.<br>2. The bank's stock price plummeted by as much as 20% in after-hours trading after the announcement of the internal control weaknesses and CEO replacement.<br>3. Appointment of Alessandro DiNello as the new CEO may indicate a strategic shift in leadership and a potential turnaround for the company.</td>
      <td>1. The material weaknesses in loan risk tracking and the significant increase in fourth-quarter loss raise concerns about the bank's overall financial health.<br>2. The abrupt change in CEO and the turmoil within the company may lead to uncertainty and instability in the short term.<br>3. The delay in filing the 10-K report and the need for internal reviews could indicate further issues with the bank's financial reporting.</td>
      <td>Financial Health<br>Leadership Change<br>Turmoil<br>Stock Price Volatility<br>Strategic Shift</td>
      <td>524.82</td>
      <td>-54.34</td>
    </tr>
    <tr>
      <td>7</td>
      <td>Small</td>
      <td><a href="https://xueqiu.com/S/RKLB">RKLB<br>Rocket Lab USA</a></td>
      <td>1. Rocket Lab USA, Inc. has reported strong performance in its full-year 2023 results despite a net loss increase<br>2. The introduction of a family of spacecraft buses is a positive development and showcases Rocket Lab’s space systems capabilities<br>3. The successful return of a custom spacecraft for Varda Space Industries highlights Rocket Lab’s expertise in in-space manufacturing and logistics</td>
      <td>1. The net loss increase reported by Rocket Lab USA, Inc. is a cause for concern and requires further analysis of the company’s financial health<br>2. The competitive nature of the space industry and the need for frequent and reliable space access present potential risks for Rocket Lab<br>3. Investment in equipment financing and ongoing rocket launches carry inherent risks and need to be managed effectively</td>
      <td>Space Industry<br>Rocket Launches<br>Financial Performance<br>Space Systems Capabilities<br>In-space Manufacturing</td>
      <td>508.55</td>
      <td>2.23</td>
    </tr>
    <tr>
      <td>8</td>
      <td>Small</td>
      <td><a href="https://xueqiu.com/S/SOFI">SOFI<br>SoFi</a></td>
      <td>1. SoFi Technologies is diversifying its business operations beyond lending, which could lead to new revenue sources<br>2. The company's financial results have been impressive, indicating strong potential for growth<br>3. Cathie Wood's continued interest in the stock suggests a positive outlook for investors<br>4. The thriving digital banking sector presents a lucrative opportunity for SoFi Technologies<br>5. The technology platform segment of the company is poised for growth and increased revenue</td>
      <td>1. Investors may remain cautious about the company's transition away from its core lending business<br>2. The market's perception of SoFi Technologies as a real, chartered bank may impact the stock's valuation<br>3. Shorting hot stocks like SoFi Technologies may carry significant risk due to market irrationality<br>4. The transformation in traditional banking may pose challenges and uncertainties for the company<br>5. Competition in the fintech and digital banking space could affect SoFi Technologies' market position</td>
      <td>Fintech<br>Digital Banking<br>Financial Services<br>Investment<br>Growth Potential</td>
      <td>441.78</td>
      <td>-7.04</td>
    </tr>
    <tr>
      <td>9</td>
      <td>Small</td>
      <td><a href="https://xueqiu.com/S/TGTX">TGTX<br>TG Therapeutics</a></td>
      <td>1. TG Therapeutics beat earnings expectations in Q4 2023, indicating strong financial performance<br>2. Sales of its multiple sclerosis treatment met expectations, leading to a surge in TGTX stock<br>3. The issuance of additional patents by the USPTO extends the exclusivity of ublituximab through 2042, securing the company’s position in the market</td>
      <td>1. TG Therapeutics is not one of the most popular stocks among hedge funds, which may indicate lower investor confidence<br>2. The company’s future revenue guidance for BRIUMVI is set between $220 - $260 million, and any deviation from this range could impact the stock price<br>3. The launch of BRIUMVI in Europe by its ex-US partner introduces potential regulatory and market challenges</td>
      <td>Biopharmaceuticals<br>Earnings<br>Patents<br>Market Expansion<br>Multiple Sclerosis Treatment</td>
      <td>361.28</td>
      <td>-5.33</td>
    </tr>
    <tr>
      <td>10</td>
      <td>Middle</td>
      <td><a href="https://xueqiu.com/S/GEN">GEN<br>nan</a></td>
      <td>1. Gen Digital's fair value estimate is US$38.03 according to the 2 Stage Free Cash Flow to Equity analysis.<br>2. Avast, a brand of Gen Digital, blocked an unprecedented 10 billion attacks in 2023, which shows the company's strong performance in digital security.</td>
      <td>1. Gen Digital's recent quarterly report and forward guidance didn't give investors much to be excited about, signaling potential challenges ahead.<br>2. The company posted results that missed estimates and reduced its revenue and earnings guidance, indicating a potential decrease in financial performance.</td>
      <td>Cybersecurity<br>Digital security<br>Revenue guidance<br>Earnings estimate<br>Stock performance</td>
      <td>457.79</td>
      <td>-6.81</td>
    </tr>
    <tr>
      <td>11</td>
      <td>Mega</td>
      <td><a href="https://xueqiu.com/S/META">META<br>Meta Platforms</a></td>
      <td>1. Meta stock is trading tightly near a high after the earnings gap-up.<br>2. Meta Platforms said it will stop paying Australian news publishers for content that appears on Facebook, setting up a fresh battle with Canberra.<br>3. Among the Magnificent Seven stocks to buy and watch, Apple, Nvidia and Tesla stock are in new buy areas.</td>
      <td>1. European consumer rights groups are accusing Meta of carrying out a 'massive' and 'illegal' operation of collecting data from hundreds of millions of its users in the region.<br>2. Meta Platforms may face challenges with its decision to stop paying Australian news publishers for content on Facebook, leading to potential regulatory and public relations risks.<br>3. Billionaire Ray Dalio mentioned that Meta Platforms stock is 'somewhat cheap', indicating potential overvaluation.</td>
      <td>Stock Analysis<br>Social Media<br>Regulatory Risks<br>Earnings Gap-up<br>Data Privacy</td>
      <td>349.01</td>
      <td>42.43</td>
    </tr>
  </tbody>
</table><script src="static/tablesort.min.js"></script><script src="static/tablesort.number.min.js"></script><script>new Tablesort(document.getElementById("container"));</script></body></html>